Pneumococcal meningitis in adults: a prospective nationwide cohort studY over a 20-year period.

Diederik L H KoelmanMatthijs C BrouwerLiora Ter HorstMerijn W BijlsmaArie van der EndeDiederik van de Beek

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Implementation of conjugate vaccines and adjunctive dexamethasone therapy have changed the incidence and outcome of pneumococcal meningitis in adults over the last two decades. Despite recent advances pneumococcal meningitis remains associated with a residual high rate of mortality and morbidity.

Keyphrases

cerebrospinal fluid
risk factors
primary care
healthcare
high dose
cardiovascular events
quality improvement
mesenchymal stem cells
coronary artery disease
smoking cessation